Xilio Development Inc Earnings

The next earnings date for Xilio Development Inc is November 6, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Xilio Development Inc Earnings

Report Date	Estimated Earnings Per Share
11/06/2025	$-0.05

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Xilio Development Inc Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/14/2025	---	$-0.16	-60.00%
08/08/2025	---	$0	100.00%
08/06/2025	---	$0	100.00%
06/13/2025	After Market	$-0.18	-63.64%
11/09/2024	Before Market	$-0.22	12.00%
08/08/2024	Before Market	$-0.24	-4.35%
05/14/2024	Before Market	$-0.62	-463.64%
02/07/2024	After Market	$-0.64	0.00%
11/09/2023	After Market	$-0.61	24.69%
08/14/2023	Before Market	$-0.70	19.54%
05/09/2023	Before Market	$-0.83	6.74%
03/02/2023	After Market	$-0.82	-5.13%
11/09/2022	Before Market	$-0.72	18.18%
08/09/2022	Before Market	$-0.90	-15.38%
05/12/2022	Before Market	$-0.78	16.13%
03/01/2022	Before Market	$-0.98	16.24%
12/02/2021	Before Market	$-21.27	-1,229.38%
09/01/2021	---	$-2.28	---
05/24/2021	---	$-0.63	---
03/31/2021	---	$-23.53	---
12/31/2020	---	$-27.93	---
09/30/2020	---	$-27.93	---
06/30/2020	---	$-27.98	---
03/31/2020	---	$-19.83	---

More About Xilio Development Inc

Website

https://xiliotx.com

Country

USA

Full Time Employees

Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.

“Xilio Development Inc Earnings” Can Refer to the Xilio Development Inc Earnings Date

Some people say “Xilio Development Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Xilio Development Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Xilio Development Inc Stock on the Earnings Date

If you own Xilio Development Inc stock (XLO) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Xilio Development Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Xilio Development Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Xilio Development Inc Earnings

You can contact us any time if you would like to ask questions about Xilio Development Inc earnings or anything else related to the stock market.